Alaunos Therapeutics (TCRT) Payables (2009 - 2026)
Alaunos Therapeutics (TCRT) reported Payables of $400000.0 for Q1 2026, up 52.67% on a YoY basis from $262000.0 in Q1 2025, and down 34.75% quarter-over-quarter from $613000.0 in Q4 2025.
Alaunos Therapeutics (TCRT) Payables (2009 - 2026) Analysis & Trends
Alaunos Therapeutics has reported Payables for 18 years, with the latest figure at $400000.0 in Q1 2026.
- For the quarter ending Q1 2026, Payables rose 52.67% year-over-year to $400000.0; the trailing twelve-month figure through Mar 2026 stood at $400000.0 (up 52.67% YoY), and the FY2025 full-year result was $613000.0, up 18.8% from the prior year.
- Payables for Q1 2026 stood at $400000.0, down from $613000.0 in the prior quarter.
- The five-year high for Payables was $2.0 million in Q3 2022, with the low at $262000.0 in Q1 2025.
- Historically, Payables has averaged $797882.4 across 5 years, with a median of $605000.0 in 2022.
- Annual changes were most pronounced in 2022 — Payables slumped 85.56% — and 2023, when it soared 212.03%.
- Alaunos Therapeutics' Payables stood at $1.4 million in 2022, then slumped by 55.65% to $616000.0 in 2023, then declined by 16.23% to $516000.0 in 2024, then climbed by 18.8% to $613000.0 in 2025, then plunged by 34.75% to $400000.0 in 2026.
- The last three Payables figures came in at $400000.0 (Q1 2026), $613000.0 (Q4 2025), and $843000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - | 400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 400,000.00 |
| Dec 31, 2025 | 613,000.00 |
| Sep 30, 2025 | 843,000.00 |
| Jun 30, 2025 | 285,000.00 |
| Mar 31, 2025 | 262,000.00 |
| Dec 31, 2024 | 516,000.00 |
| Sep 30, 2024 | 458,000.00 |
| Jun 30, 2024 | 365,000.00 |
| Mar 31, 2024 | 597,000.00 |
| Dec 31, 2023 | 616,000.00 |
| Sep 30, 2023 | 1.30 Mn |
| Jun 30, 2023 | 1.48 Mn |
| Mar 31, 2023 | 1.38 Mn |
| Dec 31, 2022 | 1.39 Mn |
| Sep 30, 2022 | 1.98 Mn |
| Jun 30, 2022 | 474,000.00 |
| Mar 31, 2022 | 605,000.00 |
| Dec 31, 2021 | 1.37 Mn |
| Sep 30, 2021 | 1.46 Mn |
| Jun 30, 2021 | 982,000.00 |